Trial
NCT05091684
Administration of Fibrinogen Concentrate for Refractory Bleeding
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Collaborators
Institut de Cancérologie de la Loire
Condition
Hematological Patients
Intervention
Fibrinogen Concentrate Human
Why stopped
Only one patient was included in this study due to overly restrictive inclusion and exclusion criteria.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-23